Syncona Limited invests in and develops companies within the biotechnology and healthcare sectors, focusing on therapies that address significant medical challenges. Its investment objective is to support businesses that aim to improve and prolong human life. The trust operates primarily in the life sciences sector, making it a peer of other trusts with similar mandates and geographic focus.